Search Results - "Jasone Monasterio"

Refine Results
  1. 1

    Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke by MONTANER, Joan, MOLINA, Carlos A, MONASTERIO, Jasone, ABILLEIRA, Sonia, ARENILLAS, Juan F, RIBO, Marc, QUINTANA, Manolo, ALVAREZ-SABIN, José

    Published in Circulation (New York, N.Y.) (04-02-2003)
    “…Matrix metalloproteinase (MMP) expression is related to blood brain barrier disruption after cerebral ischemia. Moreover, MMP inhibitors reduce hemorrhagic…”
    Get full text
    Journal Article
  2. 2

    Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage by ABILLEIRA, Sonia, MONTANER, Joan, MOLINA, Carlos A, MONASTERIO, Jasone, CASTILLO, José, ALVAREZ-SABIN, José

    Published in Journal of neurosurgery (01-07-2003)
    “…Matrix metalloproteinases (MMPs) are overexpressed in the presence of some neurological diseases in which blood-brain barrier disruption exists. The authors…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Plasmatic Level of Neuroinflammatory Markers Predict the Extent of Diffusion-Weighted Image Lesions in Hyperacute Stroke by Montaner, Joan, Rovira, Alex, Molina, Carlos A., Arenillas, Juan F., Ribó, Marc, Chacón, Pilar, Monasterio, Jasone, Alvarez-Sabín, José

    “…Sixteen patients with acute middle cerebral artery stroke were studied to correlate neuroinflammatory markers with perfusion- and diffusion-weighted magnetic…”
    Get full text
    Journal Article
  5. 5

    Thrombin-activable fibrinolysis inhibitor levels in the acute phase of ischemic stroke by MONTANER, Joan, RIBO, Marc, MONASTERIO, Jasone, MOLINA, Carlos A, ALVAREZ-SABIN, José

    Published in Stroke (1970) (01-04-2003)
    “…Thrombin-activable fibrinolysis inhibitor (TAFI) is a recently identified fibrinolysis inhibitor in plasma. The purpose of this work was to study TAFI levels…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis by Figueras, Jaume, Monasterio, Jasone, Domingo, Enric, Meneses, Beatriz, Nieto, Elsa, Cortadellas, Josefa, Garcia-Dorado, David

    Published in Thrombosis journal (27-05-2011)
    “…Patients with vasospastic (VA) or non vasospastic angina (NVA) without significant coronary stenosis have a reduced risk of infarction but is unclear whether…”
    Get full text
    Journal Article
  8. 8

    Increased plasma fibrinolytic activity in bleeding gastrointestinal angiodysplasia by Junquera, Félix, Saperas, Esteban, Anglés, Ana, Abadía, Carmen, Monasterio, Jasone, Malagelada, Juan-Ramón

    “…OBJECTIVEGastrointestinal angiodysplasia is a major cause of recurrent bleeding. Haemostatic abnormalities have been implicated in the haemorrhage from these…”
    Get full text
    Journal Article
  9. 9

    Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: Relationship to clinical and radiological outcome by ALVAREZ-SABIN, José, DELGADO, Pilar, ABILLEIRA, Sonia, MOLINA, Carlos A, ARENILLAS, Juan, RIBO, Marc, SANTAMARINA, Esteban, QUINTANA, Manolo, MONASTERIO, Jasone, MONTANER, Joan

    Published in Stroke (1970) (01-06-2004)
    “…Matrix metalloproteinases (MMPs) are related to blood-brain barrier disruption, and some members of this family have been recently involved in brain bleedings…”
    Get full text
    Journal Article
  10. 10

    Matrix metalloproteinase expression after human cardioembolic stroke: Temporal profile and relation to neurological impairment by MONTANER, Joan, ALVAREZ-SABIN, José, MOLINA, Carlos, ANGLES, Ana, ABILLEIRA, Sonia, ARENILLAS, Juan, GONZALEZ, Miguel Angel, MONASTERIO, Jasone

    Published in Stroke (1970) (01-08-2001)
    “…Uncontrolled expression of matrix metalloproteinases (MMPs) can result in tissue injury and inflammation. In animal models of cerebral ischemia, the expression…”
    Get full text
    Journal Article
  11. 11

    Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction by Figueras, Jaume, Monasterio, Jasone, Lidón, Rosa M, Sambola, Antonia, Garcia-Dorado, David

    Published in Thrombosis research (01-09-2012)
    “…Abstract Introduction Mechanisms to explain the different course of coronary thrombosis between ST elevation myocardial infarction (STEMI) and non-STEMI…”
    Get full text
    Journal Article
  12. 12

    Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions by Alemán, Carmen, Alegre, José, Monasterio, Jasone, Segura, Rosa M, Armadans, Lluís, Anglés, Ana, Varela, Encarna, Ruiz, Eva, Fernández de Sevilla, Tomás

    Published in Clinical science (1979) (01-11-2003)
    “…The response of the fibrinolytic system to inflammatory mediators in empyema and complicated parapneumonic pleural effusions is still uncertain. We…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions by Ruiz, Eva, Alemán, Carmen, Alegre, José, Monasterio, Jasone, Segura, Rosa Ma, Armadans, Lluis, Vázquez, Ana, Soriano, Teresa, Fernández de Sevilla, Tomás

    Published in Lung (01-06-2005)
    “…The angiogenesis system has been implicated in inflammatory and neoplastic processes; nevertheless, it has been little studied in relation to the pleural…”
    Get full text
    Journal Article
  15. 15

    Tissue factor levels and high ratio of fibrinopeptide A:D‐dimer as a measure of endothelial procoagulant disorder in pre‐eclampsia by Bellart, Jordi, Gilabert, Rosa, Anglès, Anna, Piera, Veronica, Miralles, Ramón M., Monasterio, Jasone, Cabero, Lluis

    “…To assess coagulation activation and endothelial cell injury in normotensive and pre‐eclamptic pregnant women, a comparision was made of plama levels of tissue…”
    Get full text
    Journal Article
  16. 16

    Disfunción endotelial y desequilibrio hemostásico en el síndrome X cardiológico by Meneses, Beatriz, Baró, Francesc, Monasterio, Jasone, Quiroga, Adoración, Bermúdez, Pilar, Figueras, Jaume

    Published in Progresos de obstetricia y ginecología (01-04-2006)
    “…La posible existencia de disfunción endotelial y desequilibrio hemostásico en syndrome X cardiológico, frecuente en la posmenopausia, es un tema controvertido…”
    Get full text
    Journal Article
  17. 17

    931-112 A Low-dose Intravenous Aspirin, Bolus Injection, Effectively Inhibits Platelet Aggregation by Lidòn, Rosa-Maria, Garcia-Dorado, David, Figueras, Jaume, Oliveras, Juan, Anglès, Anna, Monasterio, Jasone, Soler-Soler, J., Thèroux, Pierre

    “…Prompt inhibition of platelet aggregation is important in acute coronary syndrome and before an intervention procedure. To determine whether a single low dose…”
    Get full text
    Journal Article
  18. 18

    Effects of two different doses of hirudin on APTT, determined with eight different reagents by Monreal, M, Monreal, L, Ruiz de Gopegui, R, Espada, Y, Angles, A M, Monasterio, J

    Published in Thrombosis and haemostasis (1995)
    “…The APTT has been considered the most suitable candidate to monitor the anticoagulant activity of hirudin. However, its use is hampered by problems of…”
    Get more information
    Journal Article
  19. 19

    Effects of recombinant hirudin on D dimer levels before and after experimental venous thrombosis by Monreal, M, Angles, A M, Monreal, L, Roncales, J, Monasterio, J

    Published in Haemostasis (01-11-1994)
    “…In a randomized, blind study, the effect of saline, a low-molecular-weight heparin (Fragmin), and a recombinant hirudin (CGP 39393) on thrombin-antithrombin…”
    Get more information
    Journal Article
  20. 20

    Comparative study on the antithrombotic efficacy of four low-molecular-weight heparins in three different models of experimental venous thrombosis by Monreal, M, Silveira, P, Monreal, L, Monasterio, J, Angles, A M, Lafoz, E, Lorente, L

    Published in Haemostasis (1991)
    “…In a randomized, blind study, both the antithrombotic efficacy (reduction of thrombus weight) and potency (anti-Xa activity) of several commercially available…”
    Get more information
    Journal Article